These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11784244)

  • 1. Prediction of cardiovascular mortality.
    Levitt JI
    Arch Intern Med; 2002 Jan; 162(1):108; author reply 109-10. PubMed ID: 11784244
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up.
    Harari G; Green MS; Magid A; Zelber-Sagi S
    Am J Cardiol; 2017 Apr; 119(8):1193-1198. PubMed ID: 28267961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too.
    Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
    Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
    Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study.
    Criqui MH; Cowan LD; Tyroler HA; Bangdiwala S; Heiss G; Wallace RB; Cohn R
    Am J Epidemiol; 1987 Oct; 126(4):629-37. PubMed ID: 3631053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter by Lund et al regarding article, "fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events".
    Lund SS; Vaag AA; Jensen T
    Circulation; 2009 Apr; 119(13):e384; author reply e385. PubMed ID: 19349329
    [No Abstract]   [Full Text] [Related]  

  • 8. The great fat debate: reducing cholesterol.
    Kuller LH
    J Am Diet Assoc; 2011 May; 111(5):663-4. PubMed ID: 21515108
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target.
    Grundy SM
    Arch Intern Med; 2001 Jun; 161(11):1379-80. PubMed ID: 11386886
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No-HDL-cholesterol as risk marker and therapeutic goal.
    Millán Núnez-Cortés J
    Clin Investig Arterioscler; 2018; 30(2):72-73. PubMed ID: 29571430
    [No Abstract]   [Full Text] [Related]  

  • 14. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
    Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
    Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol: ready for prime time?
    Kon YC
    Singapore Med J; 2005 Oct; 46(10):507-13. PubMed ID: 16172769
    [No Abstract]   [Full Text] [Related]  

  • 18. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Does low-density lipoprotein cholesterol influence the relationship between high-density lipoprotein cholesterol and cardiovascular risk in women?
    Ann Intern Med; 2011 Dec; 155(11):I56. PubMed ID: 22147728
    [No Abstract]   [Full Text] [Related]  

  • 20. Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?
    Reiner Ž
    Cardiology; 2015; 131(4):225-7. PubMed ID: 25968652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.